guest ::
| Home > Publications database > Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer. > print |
| Home > Publications database > Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer. > print |
| 001 | 177908 | ||
| 005 | 20240229133754.0 | ||
| 024 | 7 | _ | |a 10.1111/odi.13502 |2 doi |
| 024 | 7 | _ | |a pmid:32569410 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC7752834 |2 pmc |
| 024 | 7 | _ | |a 1354-523X |2 ISSN |
| 024 | 7 | _ | |a 1601-0825 |2 ISSN |
| 024 | 7 | _ | |a altmetric:89250001 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-02930 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Bravi, Francesca |0 0000-0003-0173-5319 |b 0 |
| 245 | _ | _ | |a Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer. |
| 260 | _ | _ | |a Oxford [u.a.] |c 2021 |b Wiley-Blackwell |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1639052087_22608 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a To summarize the latest evidence on head and neck cancer epidemiology from the International Head and Neck Cancer Epidemiology (INHANCE) consortium.INHANCE was established in 2004 to elucidate the etiology of head and neck cancer through pooled analyses of individual-level data on a large scale. We summarize results from recent INHANCE-based publications updating our 2015 overview.Seventeen papers were published between 2015 and May 2020. These studies further define the nature of risks associated with tobacco and alcohol, and occupational exposures on head and neck cancer. The beneficial effects on incidence of head and neck cancer were identified for good oral health, endogenous and exogenous hormonal factors, and selected aspects of diet related to fruit and vegetables. INHANCE has begun to develop risk prediction models and to pool follow-up data on their studies, finding that ~30% of cases had cancer recurrence and 9% second primary cancers, with overall- and disease-specific 5-year-survival of 51% and 57%, respectively.The number and importance of INHANCE scientific findings provides further evidence of the advantages of large-scale internationally collaborative projects and will support the development of prevention strategies. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
| 650 | _ | 7 | |a INHANCE |2 Other |
| 650 | _ | 7 | |a head and neck cancer |2 Other |
| 650 | _ | 7 | |a laryngeal cancer |2 Other |
| 650 | _ | 7 | |a oral cavity cancer |2 Other |
| 650 | _ | 7 | |a pooled analysis |2 Other |
| 650 | _ | 7 | |a prognostic factors |2 Other |
| 650 | _ | 7 | |a risk factors |2 Other |
| 650 | _ | 2 | |a Case-Control Studies |2 MeSH |
| 650 | _ | 2 | |a Head and Neck Neoplasms: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Neoplasm Recurrence, Local |2 MeSH |
| 650 | _ | 2 | |a Risk Factors |2 MeSH |
| 650 | _ | 2 | |a Tobacco Use |2 MeSH |
| 700 | 1 | _ | |a Lee, Yuan-Chin Amy |b 1 |
| 700 | 1 | _ | |a Hashibe, Mia |0 0000-0002-6903-2049 |b 2 |
| 700 | 1 | _ | |a Boffetta, Paolo |0 0000-0002-3811-2791 |b 3 |
| 700 | 1 | _ | |a Conway, David I |0 0000-0001-7762-4063 |b 4 |
| 700 | 1 | _ | |a Ferraroni, Monica |0 0000-0002-4542-4996 |b 5 |
| 700 | 1 | _ | |a La Vecchia, Carlo |0 0000-0003-1441-897X |b 6 |
| 700 | 1 | _ | |a Edefonti, Valeria |0 0000-0002-1995-1477 |b 7 |
| 700 | 1 | _ | |a investigators, INHANCE Consortium |b 8 |e Collaboration Author |
| 700 | 1 | _ | |a Agudo, Antonio |b 9 |
| 700 | 1 | _ | |a Ahrens, Wolfgang |b 10 |
| 700 | 1 | _ | |a Benhamou, Simone |b 11 |
| 700 | 1 | _ | |a Boccia, Stefania |b 12 |
| 700 | 1 | _ | |a Brennan, Paul |b 13 |
| 700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 14 |u dkfz |
| 700 | 1 | _ | |a Cadoni, Gabriella |b 15 |
| 700 | 1 | _ | |a Canova, Cristina |b 16 |
| 700 | 1 | _ | |a Chen, Chu |b 17 |
| 700 | 1 | _ | |a Chuang, Shu-Chun |b 18 |
| 700 | 1 | _ | |a Curado, Maria Paula |b 19 |
| 700 | 1 | _ | |a Dal Maso, Luigino |b 20 |
| 700 | 1 | _ | |a Daudt, Alexander W |b 21 |
| 700 | 1 | _ | |a D'Souza, Gypsyamber |b 22 |
| 700 | 1 | _ | |a Fabianova, Eleonora |b 23 |
| 700 | 1 | _ | |a Fernandez, Leticia |b 24 |
| 700 | 1 | _ | |a Franceschi, Silvia |b 25 |
| 700 | 1 | _ | |a Garavello, Werner |b 26 |
| 700 | 1 | _ | |a Gillison, Maura |b 27 |
| 700 | 1 | _ | |a Gross, Neil D |b 28 |
| 700 | 1 | _ | |a Hayes, Richard B |b 29 |
| 700 | 1 | _ | |a Healy, Claire |b 30 |
| 700 | 1 | _ | |a Herrero, Rolando |b 31 |
| 700 | 1 | _ | |a Holcatova, Ivana |b 32 |
| 700 | 1 | _ | |a Kelsey, Karl |b 33 |
| 700 | 1 | _ | |a Kjaerheim, Kristina |b 34 |
| 700 | 1 | _ | |a Koifman, Rosalina |b 35 |
| 700 | 1 | _ | |a Lagiou, Pagona |b 36 |
| 700 | 1 | _ | |a Lazarus, Philip |b 37 |
| 700 | 1 | _ | |a Levi, Fabio |b 38 |
| 700 | 1 | _ | |a Li, Guojun |b 39 |
| 700 | 1 | _ | |a Lissowska, Jolanta |b 40 |
| 700 | 1 | _ | |a Luce, Daniele |b 41 |
| 700 | 1 | _ | |a Macfarlane, Gary J |b 42 |
| 700 | 1 | _ | |a Mates, Dana |b 43 |
| 700 | 1 | _ | |a Matsuo, Keitaro |b 44 |
| 700 | 1 | _ | |a McClean, Michael |b 45 |
| 700 | 1 | _ | |a Menezes, Ana |b 46 |
| 700 | 1 | _ | |a Menvielle, Gwenn |b 47 |
| 700 | 1 | _ | |a Morgenstern, Hal |b 48 |
| 700 | 1 | _ | |a Moyses, Raquel A |b 49 |
| 700 | 1 | _ | |a Moysich, Kirsten |b 50 |
| 700 | 1 | _ | |a Muscat, Joshua |b 51 |
| 700 | 1 | _ | |a Negri, Eva |b 52 |
| 700 | 1 | _ | |a Olshan, Andrew F |b 53 |
| 700 | 1 | _ | |a Pandics, Tamas |b 54 |
| 700 | 1 | _ | |a Polesel, Jerry |b 55 |
| 700 | 1 | _ | |a Purdue, Mark P |b 56 |
| 700 | 1 | _ | |a Radoï, Loredana |b 57 |
| 700 | 1 | _ | |a Ramroth, Heribert |b 58 |
| 700 | 1 | _ | |a Richiardi, Lorenzo |b 59 |
| 700 | 1 | _ | |a Schantz, Stimson |b 60 |
| 700 | 1 | _ | |a Schwartz, Stephen M |b 61 |
| 700 | 1 | _ | |a Serraino, Diego |b 62 |
| 700 | 1 | _ | |a Shangina, Oxana |b 63 |
| 700 | 1 | _ | |a Smith, Elaine |b 64 |
| 700 | 1 | _ | |a Sturgis, Erich M |b 65 |
| 700 | 1 | _ | |a Świątkowska, Beata |b 66 |
| 700 | 1 | _ | |a Thomson, Peter |b 67 |
| 700 | 1 | _ | |a Toporcov, Tatiana N |b 68 |
| 700 | 1 | _ | |a Vaughan, Thomas L |b 69 |
| 700 | 1 | _ | |a Vilensky, Marta |b 70 |
| 700 | 1 | _ | |a Winn, Deborah M |b 71 |
| 700 | 1 | _ | |a Wunsch-Filho, Victor |b 72 |
| 700 | 1 | _ | |a Yu, Guo-Pei |b 73 |
| 700 | 1 | _ | |a Zevallos, Jose P |b 74 |
| 700 | 1 | _ | |a Zhang, Zuo-Feng |b 75 |
| 700 | 1 | _ | |a Zheng, Tongzhang |b 76 |
| 700 | 1 | _ | |a Znaor, Ariana |b 77 |
| 773 | _ | _ | |a 10.1111/odi.13502 |g Vol. 27, no. 1, p. 73 - 93 |0 PERI:(DE-600)2008428-6 |n 1 |p 73 - 93 |t Oral diseases |v 27 |y 2021 |x 1354-523X |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:177908 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2021-01-27 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ORAL DIS : 2019 |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-01-27 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2021-01-27 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-01-27 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-01-27 |
| 920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C070-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|